Phenotype of regenerative epithelium in idiopathic interstitial pneumonias

Journal of Medical and Dental Sciences

Volumn 50, Issue 3, 2003, Pages 213-224

  Hinata, Nae ^a,b   Takemura, Tamiko ^b   Ikushima, Soichiro ^b   Yanagawa, Takashi ^b   Ando, Tsunehiro ^b   Okada, Junko ^b   Oritsu, Masaru ^b   Koike, Morio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Bronchiolar basal cell; NSIP; Phenotype; Regenerative epithelium; UIP

Indexed keywords

ANTIGEN; APOPROTEIN; CLARA CELL SPECIFIC PROTEIN; CLARA CELL-SPECIFIC PROTEIN; ENZYME INHIBITOR; GLYCOPROTEIN; KERATIN; MUC1 PROTEIN, HUMAN; MUCIN; PHOSPHOLIPASE; PROTEIN; PULMONARY SURFACTANT APOPROTEIN; SURFACTANT ASSOCIATED PROTEIN; TGFB2 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; TUMOR ANTIGEN; UTEROGLOBIN;

ARTICLE; BRONCHUS; CYTOLOGY; DRUG ANTAGONISM; EPITHELIUM CELL; FEMALE; FIBROBLAST; FIBROSIS; GENETICS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG; LUNG TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PHENOTYPE; REGENERATION;

ANTIGENS; ANTIGENS, NEOPLASM; APOPROTEINS; BRONCHI; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; FIBROSIS; GLYCOPROTEINS; HUMANS; KERATINS; LUNG; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUCINS; PHENOTYPE; PHOSPHOLIPASES; PROTEINS; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; REGENERATION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; UTEROGLOBIN;

EID: 2342516124     PISSN: 13428810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American thoracic society. American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
2. American thoracic society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000;161:646-64.
3. Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-15.
4. Liebow AA. Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res 1975;8:1-33.
5. Travis WD, Matsui K, Moss J, et al. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns. Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24:19-33.
6. Rannels SR, Fisher CS, Heuser LJ, et al. Culture of type II pneumocytes on a type II cell-derived fibronectin-rich matrix. Am J Physiol 1987;253:759-65.
7. Dunsmore SE, Martinez-Williams C, Goodman RA, et al. Turnover of fibronectin and laminin by alveolar epithelial cells. Am J Physiol 1995;269:766-75.
8. Kawanami O, Ferrans VJ, Crystal RG. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest 1982;46:39-53.
9. Iyonaga K, Miyajima M, Suga M, et al. Alterations in cytokeratin expression by the alveolar lining epithelial cells in lung tissues from patients with idiopathic pulmonary fibrosis. J Pathol 1997;182:217-24.
10. Otto WR. Lung epithelial stem cells. J Pathol 2002;197:527-35.
11. Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 2002;161:173-82.
12. Evans MJ, Cabral-Anderson LJ, Freeman G. Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest 1978;38:648-53.
13. Hermans C, Bernard A. Lung epithelium-specific proteins. Characteristics and potential applications as markers. Am J Respir Crit Care Med 1999;159:646-78.
14. Kuroki Y, Mason RJ, Voelker DR. Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 1998;263:3388-94.
15. Kohno N, Akiyama M, Kyoizumi S, et al. Detection of soluble tumor- associated antigens is sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18:203-16.
16. Kohno N, Kyoizumi S, Awaya Y, et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6 Chest 1989;96:68-73.
17. Khalil N, O'Connor RN, Unruh HW, et al. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991;5:155-62.
18. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-45.
19. Katzenstein ALA, Fiorelli RF. Nonspecific interstitial pneumonia/ fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47.
20. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1998;41:467-70.
21. Lesur O, Bernard A, Arsalane K, et al. Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995;152:290-7.
22. Johnston CJ, Mango GW, Finkelstein JN, et al. Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. Am J Respir Cell Mol Biol 1997;17:147-55.
23. Antoniades HN, Bravo MA, Avila RE, et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990;86:1055-64.
24. Takahashi H, Fujishima T, Koba H, et al. Serum surfactant protein A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 2000;162:1109-14.
25. Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 1999;46:151-8.
26. Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 2002;165:378-81.
27. Kobayashi J, Kitamura S. KL-6: A serum marker for interstitial pneumonia. Chest 1995;108:311-5.
28. Yokoyama A, Kohno N, Hamada H, et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1680-4.
29. Hirasawa Y, Kohno N, Yokoyama A, et al. KL-6, a human MUC1 mucin, is chemotactic for human fibrosis. Am J Respir Cell Mol Biol 1997;17:501-7.
30. 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: An immunohistochemical study. Am J Respir Cell Mol Biol 1996;14:131-8.
31. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-β. J Exp Med 1987;165:251-6.